BIN1 and Schnyder corneal dystrophy: Furthermore, in a diagnostic structure combining clinical diagnosis and biomarkers (Fig. 1C), SCD participants with A+(SCD+) had much lower methylation levels of BIN1 promoter than CN participants without significant Aβ42 pathological changes (CN−) (p < 0.0001).